GLYBURIDE (MICRONIZED) Drug Patent Profile
When do Glyburide (micronized) patents expire, and what generic alternatives are available?
Glyburide (micronized) is a drug marketed by Chartwell Rx, Hikma, Natco Pharma, Sanofi Aventis Us, Strides Pharma Intl, and Teva. and is included in six NDAs.
The generic ingredient in GLYBURIDE (MICRONIZED) is glyburide. There is one drug master file entry for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the glyburide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glyburide (micronized)
A generic version of GLYBURIDE (MICRONIZED) was approved as glyburide by TEVA on August 29th, 1995.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GLYBURIDE (MICRONIZED)?
- What are the global sales for GLYBURIDE (MICRONIZED)?
- What is Average Wholesale Price for GLYBURIDE (MICRONIZED)?
Summary for GLYBURIDE (MICRONIZED)
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 121 |
| Patent Applications: | 4,662 |
| DailyMed Link: | GLYBURIDE (MICRONIZED) at DailyMed |
-patent-expirations.png "GLYBURIDE (MICRONIZED) drug patent expirations")
Pharmacology for GLYBURIDE (MICRONIZED)
| Drug Class | Sulfonylurea |
US Patents and Regulatory Information for GLYBURIDE (MICRONIZED)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | GLYBURIDE (MICRONIZED) | glyburide | TABLET;ORAL | 075174-001 | Jun 22, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | GLYBURIDE (MICRONIZED) | glyburide | TABLET;ORAL | 074686-003 | Apr 20, 1999 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Natco Pharma | GLYBURIDE (MICRONIZED) | glyburide | TABLET;ORAL | 074792-002 | Jun 26, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | GLYBURIDE (MICRONIZED) | glyburide | TABLET;ORAL | 075890-002 | Jul 31, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Strides Pharma Intl | GLYBURIDE (MICRONIZED) | glyburide | TABLET;ORAL | 074591-001 | Dec 22, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Natco Pharma | GLYBURIDE (MICRONIZED) | glyburide | TABLET;ORAL | 074792-003 | Aug 17, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | GLYBURIDE (MICRONIZED) | glyburide | TABLET;ORAL | 074686-004 | Apr 20, 1999 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
